Latest from Our Blog

Pulmonary Arterial Hypertension Life Expectancy & Survival Rates

The treatment for Pulmonary Arterial Hypertension has come a long way since the mid 1990’s when Flolan was first approved.  There has been an explosion of new medications that have dramatically altered how we treat patients.  We no longer sequentially add therapies to most of our patients.  Rather, we often start two or even three […]

Help Arrives for Some PAH Patients Who Can’t Afford Their Medication

Thousands of Pulmonary Arterial Hypertension patients across America are now experiencing a crisis.  They previously received support from Caring Voices Coalition. With the closing of Caring Voices, many of these patients have been unable to find foundation support, leaving them responsible for many thousands of dollars per month to receive their PAH medications. The PHA […]

Update on the Implantable System for Remodulin

On December 22, 2017, after eight years of study, the FDA has finally granted pre-market approval (PMA) to the fully implantable system for Remodulin.  This groundbreaking pump and catheter system allows patients to benefit from Remodulin while minimizing the inconvenience and risks associated with having an external intravenous catheter. However, this does not mean that […]